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 The Evolution of Training in Nuclear 
Medicine in the UK 
 Andrew  Hilson 
 Training in Nuclear Medicine in the UK has evolved over the years. This memoire 
is a personal view, based on a (fallible) memory and documents kept over the years. 
 It was in the late 1960s that physicians became involved in the developing spe-
ciality, which had been predominantly a development of the strong Medical Physics 
community. A key driver was the creation of the Institute of Nuclear Medicine at the 
Middlesex Hospital. A particular leader was Professor Edward Williams. 
 There was much discussion before the MSc was set up as an Intercollegiate Exam 
of London University. Several Nuclear Medicine physicians felt that the a degree was 
too rigid, and that there should be a diploma of the Royal College of Physicians 
(RCP) Other specialties had Diplomas – there was the DObs in Obstetrics, the DA in 
anaesthetics, the DMRD in radiology, and the DTMH in tropical medicine amongst 
many. However the Colleges were trying to get rid of Diplomas, so the MSc it was. 
 In 1971, there was a joint meeting of the British Institute of Radiology, the 
British Nuclear Medicine Society, the Faculty of Radiologists, the Hospital 
Physicists’ Association and the Section of Radiology of The Royal Society of 
Medicine, held at The Royal College of Surgeons, Lincoln’s Inn Fields, on Friday, 
May 21,1971 [ 1 ]. The Chairman was Dr. James Bull (Senior Radiologist at the 
National Hospital for Nervous Diseases). The title was “Whither Nuclear Medicine 
?” This looked at the provision of Nuclear Medicine services in the light of the 
Windeyer Report (Report of the Working Party on the Organization of Radioisotope 
Services, 1970) set up in 1966. Edward Williams gave a paper on “The training 
programme of future medical Consultants and staff of nuclear medicine depart-
ments” in which he proposed that the UK should follow Australia and consider 
Nuclear Medicine as a specialty which belonged in internal medicine, rather than 
radiology. 
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 Desmond Croft from St Thomas’s Hospital was the RCP representative on the 
UEMS, and thanks to him Nuclear Medicine was recognised as a separate specialty. 
 When I started on the MSc in 1974, the course was a 2-year course if taken 
part- time (which is what UK trainees did), or 1 year for overseas students – the 
majority. The clinical part of the course was taught via the Institute of Nuclear 
Medicine, and the science via the department of Medical Physics at the Royal 
Free Hospital School of Medicine, which had smart new teaching facilities in the 
new hospital in Hampstead (the RFHSM was the only London medical school 
which accepted candidates without A-level physics, who then had to take a 1st 
MB course). The resources included a neutron source – one of the practicals I 
remember involved producing a short-lived isotope by neutron activation then 
calculating its half-life. 
 There were lectures on PET – I remember thinking that this would never take off. 
 Nuclear Medicine in those days included much more in-vitro work, and I remem-
ber seeing with relief that one of the questions in the written paper involved giving 
a full account of an in-vitro assay. That was simple for me – I had set up and ran an 
assay for Human Placental Lactogen (HPL) – a hormone found in the blood during 
pregnancy, whose level fell about 2 weeks before birth (this was before obstetric 
ultrasound). 
 The dissertation had to be typed – I still have my copy with the text getting 
fainter as the ribbon wore out. 
 In 1993 I became an Examiner for the London University Intercollegiate Course 
for the M.Sc. in Nuclear Medicine, and in 1994 Chairman of the Board of Examiners. 
 In 1999 Manchester was approved as a teaching centre – prior to that, students 
had to be attached to a London centre. 
 In the same year the MSc underwent a major change. London University decided 
that it didn’t want to organise and validate intercollegiate courses, such as the MSc 
in Nuclear Medicine. There was again discussion about a possible College diploma, 
but this was even less popular. The Institute of Nuclear Medicine was unable to take 
over the whole course, so in 2000 the MSc moved to King’s College London School 
of Medicine (KCL). This involved a massive amount of paperwork as the course 
was remodelled to comply with their regulations. This was mainly undertaken by 
Drs Sue Clarke and Muriel Buxton-Thomas. 
 I continued as Chairman of the Board of Examiners, but at short notice KCL said 
that the post had to be occupied by a KCL academic, so Professor Ignac Fogelman 
was appointed. As he hadn’t actually set papers before, I stayed on as Intercollegiate 
examiner until 2004. 
 The rubric for the course – now the MSc Nuclear Medicine – Science and 
Practice, GKTMS – read:
 1.  Entry Requirements
•  A registrable qualifi cation in Medicine awarded by UK university or a recog-
nised European or overseas university . 
•  Two years post - registration experience in general & acute medicine ( to 
include management of medical emergencies 
•  A mark of 6.5 in each section of IELTS examination or equivalent 
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 For limited GMC registration ( exemption from PLAB ):
•  As above but must pass at 7.0 in all sections of IELTS 
 2.  Curriculum 
 The course consists of 6 modules of which 4 are taught. The 6 modules are :
 Physics & Basic Medical Science ( T ) 
 Clinical & Diagnostic Nuclear Medicine ( T ) 
 Radiopharmaceutical and Regulatory Aspects of Nuclear Medicine ( T ) 
 Therapy ,  Radiation Protection & Radiobiology ( T ) 
 Nuclear Medicine –  Practical ( P ) 
 Nuclear Medicine –  Research ( R ) 
 ( T =  Taught ,  P =  Practical and R =  Research ) 
 3.  Duration of programme of study
 Full - time :  1 year 
 Part - time :  2 years 
 4.  Examination
 Unseen written examinations :  2 Papers 
 End of Year 1 assessment viva ( part - time students ) 
 Continuous assessment consisting of 5 Assessed essays of 2000 words each , 
 logbook and 6 experiments 
 Two oral examinations ( clinical and physics ) 
 Dissertation / Report of 10 , 000 words and two Oral examinations . 
 This may seem very organised, but an idea of the true state comes from an urgent 
fax sent to the students shortly before the exams: 
 Memo to students : 
 Contrary to my previous memo there will be two written papers each of 3 h 
duration .
 Paper 1 will have two parts .
 Part 1 –  Radiopharmaceutical and Regulatory Aspects 
 Part 2 - Physics and Basic Medical Science and 
 It is recommended that students spend 1 h on Part 1 and 2 h on Part 2. Please 
bring a Scientifi c calculator to the examination . 
 Paper 2 will have two parts .
 Part 1 –  Therapy ,  Radiobiology and Radiation Protection 
 Part 2 –  Clinical / Diagnostic Nuclear Medicine 
 It is recommended that students spend 1 h on Part 1 and 2 h on Part 2 
 There were fi ve candidates, one of whom was unable to complete the examination 
as he had been called home for military service. It was possible to use the new fl exibil-
ity of KCL and award him a diploma. There was a total of seven examiners! 
 This was also the last year of the University of London MSc – there was one 
candidate re-sitting from the previous year. 
 2000–2001 was the fi rst proper year of the KCL course. There were eight stu-
dents in the second year of taking the course part time, and six new students (two 
full-time and four part-time). There was a formal 70-page prospectus giving full 
details of the course. 
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 In 2002–2003 there was a formal review by KCL, and the opportunity was taken 
to implement the options of having a Diploma and a Certifi cate. 
 A diploma course would still need a clinical attachment, but would not have a 
research module, whereas a certifi cate course would be a purely taught course with no 
practical or research and both should be able to use the MSc modules as they were. 
 Discussion took place concerning increasing the number of taught modules from 
4 to 5. These modules would be examined in 4 papers as follows:
 Paper 1: Physics & Basic Science 
 Paper 2: General Clinical (including GI, Neuro, Paediatric, Cardiovascular & 
Pulmonary Nuclear Medicine) 
 Paper 3: Radiopharmacy 
 Paper 4: Radiobiology & Radiation Protection and Therapy & Nuclear Medicine 
Oncology 
 This gave more fl exibility for offering individual modules. 
 In 2005 came Modernising Medical Careers (MMC) and new training schemes. 
 There were hours of talks between RCP, RCR and BNMS about rationalising 
training schemes. There was also much heart-searching about what sort of specialty 
Nuclear Medicine was. One good outcome was that Nuclear Medicine was recog-
nised as a shortage specialty. This led to the creation of several F2 (second-year) 
rotations with a Nuclear Medicine component. 
 In 2007–2008 there was the introduction of the concept of “Knowledge-Based 
Assessments” as an essential part of physician training. For some specialties it was 
a new exam – now known as a Specialty Certifi cate Examination. 
 For Nuclear Medicine, the Postgraduate Diploma was recognised. The MSc is 
recommended but not mandated and it was agreed in the 2007 and the 2010 
Curriculum that the PG diploma was what was regarded as equivalent to the 
Specialty Certifi cate Examination of the other Physician specialties. 
 The MSc continues at King’s College London  https://www.kcl.ac.uk/prospectus/
graduate/nuclear-medicine-science-and-practice , as part of a new training scheme 
designed to overcome the problems introduced by multimodality imaging including 
formal radiology training. However it’s too soon to tell that story. 
 The current state of play is to be found at  http://www.jrcptb.org.uk/specialties/
nuclear-medicine . 
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noncommercial use, distribution, and reproduction in any medium, provided the original author(s) 
and source are credited. 
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 The images or other third party material in this chapter are included in the work’s Creative 
Commons license, unless indicated otherwise in the credit line; if such material is not included in 
the work’s Creative Commons license and the respective action is not permitted by statutory regu-
lation, users will need to obtain permission from the license holder to duplicate, adapt or reproduce 
the material. 
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 Andrew  Hilson  I qualifi ed in 1967, when medicine was much simpler. My house jobs were in 
cardiothoracic surgery and medicine, and then I became SHO in intensive care (which didn’t 
exist). Effectively I was an applied physiologist. As I wanted to be a general physician, I did further 
jobs in general medicine, neurology and rheumatology before being offered a locum position in 
endocrinology and nuclear medicine at Guy’s hospital. I realised that this is what I wanted to do, 
and became Senior Registrar in Nuclear Medicine. This was a time of rapid growth – we bought 
the fi rst 37-tube gamma camera in the UK, then the fi rst LFOV camera, as well as one of the fi rst 
dedicated computers – the DEC GAMMA- 11 which had a full 16 k of memory. I developed an 
interest in renal nuclear medicine [ 2 ]. We moved from localising the placenta with a hand-held 
probe to using labelled RBCs, then gave it up when ultrasound came along. Phosphonate bone 
scanning revolutionised our work load, taking over from F-18-fl uoride . 
 In 1983 I became a Consultant, half time at the Royal Free Hospital and half at the Institute of 
Urology. In 1993 the Institute moved into the Middlesex Hospital, and I became full- time at the 
Royal Free. Later Dr John Buscombe joined me. 
 The department had started in Medical Physics, where its specialism was pancreas imaging 
using a subtraction technique with Selenomethionine (taken up in the liver and pancreas) and Gold 
colloid (taken up only in the liver). It also had a long tradition of work with lung aerosols, so we 
carried out some of the early work on Technegas. 
 Because the Royal Free had a major liver unit, we were the fi rst unit in the UK to use I-131-
Lipiodol therapy for hepatocellular carcinoma. This led in turn to using In-111-Octreotide initially 
for diagnosis and then for therapy in neuro-endocrine tumours. The RFH now has a world-wide 
reputation in this fi eld. We were leaders in scintimammography, which led to early involvement in 
sentinel node studies. This in turn led to my involvement in the “New Start” programme to teach 
sentinel node techniques to UK breast surgeons. 
 Inevitably, I became involved in medical politics. In addition to my involvement in the MSc, I 
was on the RCP Joint Specialty Committee from 2001, becoming Chair from 2004 to 2007; I 
served two terms on Council of the BNMS, becoming President from 2004 to 2006. 
 I have a strong interest in setting and improving standards, and was a member, of the National 
Audit and Standards Group (later Professional Standards and Education Committee) of the BNMS 
from 1995 to 2008 and was Chairman 2001–2004. I was a member of the Committee on 
Accreditation of Nuclear Medicine Departments, UEMS/EBNM) (2003–2014) and Vice-Chair 
2010–2014. I was a member of the expert panel which led to the European Commission Radiation 
Protection report No 159 “European Commission Guidelines on Clinical Audit For Medical 
Radiological Practices (Diagnostic Radiology, Nuclear Medicine and Radiotherapy)”. 
 I was an early member of the National Diagnostic Imaging Board and then was involved in the 
development of a national PET/CT strategy [ 2 ]. 
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